-The Hindu     The killings of Mahendra Karma and his colleagues call not for retributive violence but for a deeper reflection on the discontent among the tribals of central India and their dispossession In the summer of 2006, I had a long conversation with Mahendra Karma, the Chhattisgarh Congress leader who was killed in a terror attack by the Naxalites last week. I was not alone - with me were five other members...

-Countercurrents.org   The events of last over two decades have shown us, more than before that the efforts of dividing the nation by communal forces have been a major obstacle to social peace and process of development. In India while the communal violence began with the Jabalpur riot of 1961, it is from last couple of decades especially from 1980s that the divisive politics has tried to drive a wedge between different...

-The Hindu   As a sun-swept country, India should have been a pioneer in the use of solar power with a photovoltaic panel on every roof. Good policy can help make up for lost time. Solar is the most secure of all energy sources, since it is abundantly available in India. With crippling electricity shortages, the price of electricity traded internally touched Rs. 7 a unit for base loads and Rs. 8.50 during...

-The Hindu In a relief to the Centre, the Supreme Court on Wednesday upheld the government's proposal to allow foreign direct investment (FDI) in multi-brand retail trade (MBRT) saying the move did not suffer from any unconstitutionality, illegality, arbitrariness or irrationality. A three-judge bench of Justices R.M. Lodha, Madan B. Lokur and Kurian Joseph said "consumer is king and if that is the philosophy working behind the policy then what is wrong...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...